Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

McMaster University

$100,000.00

Genetic and epigenetic determinants of very early, fatal coronary artery disease

FY 2022-23

Summary
Coronary Artery Disease (CAD) is caused by the accumulation of cholesterol in the arteries providing blood to the heart muscle. It remains the leading cause of death worldwide despite declining rates for major environmental risk factors, such as smoking and blood cholesterol. Recent evidence has demonstrated the remarkable and independent roles of genetic predisposition and accelerated aging in the development of early-onset CAD (< 55 years old), since individuals who develop CAD at a young age are less likely to have developed disease due to a progressive exposure of traditional environmental risk factors like smoking. However, there remains little knowledge regarding the genetic mechanisms at play among the youngest CAD patients (< 45 years old), who have succumbed to premature death due to their condition. Although an event of very early, fatal CAD is extremely rare in the general population, we will be collaborating with the Ontario Forensic Pathology Services (OFPS) and the Office of the Chief Coroner of Ontario (OCC), which will act as a centralized repository for collecting DNA from young patients with established CAD as their cause of death. We aim to identify new genes and biomarkers of premature aging that lead to early CAD death. Indeed, our work will be the first to investigate such a severely afflicted patient population at a largescale. It will therefore serve as a foundation in using an individual's genetic signature and biological aging signature to help identify individuals and families at very high risk of CAD. Such signatures will help inform clinical therapies to reduce risk of CAD, as well as help develop new interventions.
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472641
Name
Par&eacute; Guillaume
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Genetic and epigenetic determinants of very early, fatal coronary artery disease
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Aging; Coronary Artery Disease; Epigenetics; Genetics; Mortality
Abstract
Coronary Artery Disease (CAD) is caused by the accumulation of cholesterol in the arteries providing blood to the heart muscle. It remains the leading cause of death worldwide despite declining rates for major environmental risk factors, such as smoking and blood cholesterol. Recent evidence has demonstrated the remarkable and independent roles of genetic predisposition and accelerated aging in the development of early-onset CAD (< 55 years old), since individuals who develop CAD at a young age are less likely to have developed disease due to a progressive exposure of traditional environmental risk factors like smoking. However, there remains little knowledge regarding the genetic mechanisms at play among the youngest CAD patients (< 45 years old), who have succumbed to premature death due to their condition. Although an event of very early, fatal CAD is extremely rare in the general population, we will be collaborating with the Ontario Forensic Pathology Services (OFPS) and the Office of the Chief Coroner of Ontario (OCC), which will act as a centralized repository for collecting DNA from young patients with established CAD as their cause of death. We aim to identify new genes and biomarkers of premature aging that lead to early CAD death. Indeed, our work will be the first to investigate such a severely afflicted patient population at a largescale. It will therefore serve as a foundation in using an individual's genetic signature and biological aging signature to help identify individuals and families at very high risk of CAD. Such signatures will help inform clinical therapies to reduce risk of CAD, as well as help develop new interventions.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Paré, Guillaume
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &amp;Respiratory Hlth~ $5,750~ $0~Institute of Genetics~ $94,250~ $0~